FAP-targeted PET/CT using 68Ga or 18F-labeled FAP inhibitors (FAPIs) is a highly promising imaging tool for the diagnosis, staging, monitoring recurrence, and metastasis of various cancers (8, 9). This evidence concerns the gene FAP and cancer.